219 related articles for article (PubMed ID: 37894377)
1. The Evolving Role of Stereotactic Body Radiation Therapy for Head and Neck Cancer: Where Do We Stand?
Mohamad I; Karam I; El-Sehemy A; Abu-Gheida I; Al-Ibraheem A; Al-Assaf H; Aldehaim M; Alghamdi M; Alotain I; Ashour M; Bushehri A; ElHaddad M; Hosni A
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894377
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck.
Al-Assaf H; Erler D; Karam I; Lee JW; Higgins K; Enepekides D; Zhang L; Eskander A; Poon I
Head Neck; 2020 Aug; 42(8):2050-2057. PubMed ID: 32199031
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiation Therapy in Recurrent Head and Neck Cancer: Where Do We Stand?
Nath J; Neog M; Bhattacharyya M; Kalita AK
Indian J Otolaryngol Head Neck Surg; 2024 Apr; 76(2):2212-2215. PubMed ID: 38566662
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).
Peyraga G; Lizee T; Khalifa J; Blais E; Mauriange-Turpin G; Supiot S; Krhili S; Tremolieres P; Graff-Cailleaud P
Cancer Radiother; 2021 Jun; 25(4):400-409. PubMed ID: 33478838
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: When less is enough.
Swain M; Ghosh-Laskar S
Oral Oncol; 2021 May; 116():105265. PubMed ID: 33770592
[TBL] [Abstract][Full Text] [Related]
6. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
Gogineni E; Rana Z; Vempati P; Karten J; Sharma A; Taylor P; Pereira L; Frank D; Paul D; Seetharamu N; Ghaly M
Head Neck; 2020 Oct; 42(10):2880-2886. PubMed ID: 32691496
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
Clin Lung Cancer; 2017 Mar; 18(2):105-121.e5. PubMed ID: 27908621
[TBL] [Abstract][Full Text] [Related]
9. A national cancer database analysis on stereotactic body radiation therapy of head and neck cancers.
Park JJ; Qureshi MM; Lam CM; Faden DL; Truong MT
Am J Otolaryngol; 2021; 42(3):102913. PubMed ID: 33460976
[TBL] [Abstract][Full Text] [Related]
10. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.
Kunkler IH; Audisio R; Belkacemi Y; Betz M; Gore E; Hoffe S; Kirova Y; Koper P; Lagrange JL; Markouizou A; Pfeffer R; Villa S;
Ann Oncol; 2014 Nov; 25(11):2134-2146. PubMed ID: 24625455
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
[TBL] [Abstract][Full Text] [Related]
12. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.
Doupnik NP; Hirmiz K; Hussein AA; Agapito J; Pan M
Cureus; 2022 Feb; 14(2):e21878. PubMed ID: 35273848
[TBL] [Abstract][Full Text] [Related]
13. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer.
Gogineni E; Zhang I; Rana Z; Marrero M; Gill G; Sharma A; Riegel AC; Teckie S; Ghaly M
Front Oncol; 2019; 9():836. PubMed ID: 31552172
[TBL] [Abstract][Full Text] [Related]
15. What is the best way to radiate the prostate in 2016?
Moon DH; Efstathiou JA; Chen RC
Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
[TBL] [Abstract][Full Text] [Related]
16. Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.
Mercado C; Kress MA; Cyr RA; Chen LN; Yung TM; Bullock EG; Lei S; Collins BT; Satinsky AN; Harter KW; Suy S; Dritschilo A; Lynch JH; Collins SP
Front Oncol; 2016; 6():114. PubMed ID: 27200300
[TBL] [Abstract][Full Text] [Related]
17. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis.
Chen WC; Li Y; Lazar A; Altun A; Descovich M; Nano T; Ziemer B; Sudhyadhom A; Cunha A; Thomas H; Gottschalk A; Hsu IC; Roach M
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):429-437. PubMed ID: 33385496
[TBL] [Abstract][Full Text] [Related]
19. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
20. Vertebral body fracture rates after stereotactic body radiation therapy compared with external-beam radiation therapy for metastatic spine tumors.
Vargas E; Susko MS; Mummaneni PV; Braunstein SE; Chou D
J Neurosurg Spine; 2020 Aug; 33(6):870-876. PubMed ID: 32796141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
